Tianeptine versus fluoxetine in the treatment of depression complicating Alzheimer's disease.
Sobow
T M
TM
Maczkiewicz
M
M
Kloszewska
I
I
D000544:Alzheimer Disease / Q000150:complications* / Q000523:psychology*; D018687:Antidepressive Agents, Second-Generation / Q000008:administration & dosage / Q000009:adverse effects / Q000494:pharmacology*; D000929:Antidepressive Agents, Tricyclic / Q000008:administration & dosage / Q000009:adverse effects / Q000494:pharmacology*; D003866:Depressive Disorder / Q000188:drug therapy* / Q000209:etiology; D005473:Fluoxetine / Q000008:administration & dosage / Q000009:adverse effects / Q000494:pharmacology*; D006801:Humans; D008609:Mental Status Schedule; D012189:Retrospective Studies; D013841:Thiazepines / Q000008:administration & dosage / Q000009:adverse effects / Q000494:pharmacology*; D016896:Treatment Outcome
D018687:Antidepressive Agents, Second-Generation; D000929:Antidepressive Agents, Tricyclic; D013841:Thiazepines; D005473:Fluoxetine; C050504:tianeptine